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Pyrosequencing technology is a sequencing method
that screens DNA nucleotide incorporation in real time. A
set of coupled enzymatic reactions, together with biolumi-
nescence, detects incorporated nucleotides in the form of
light pulses, which produces a profile of characteristic
peaks in a pyrogram. We used this technology to identify
the warfare agent Bacillus anthracis by sequencing 4 single
nucleotide polymorphisms (SNPs) in the rpoB gene as
chromosomal markers for B. anthracis. In addition, 1 seg-
ment in each of the B. anthracis plasmids pXO1 and pXO2
was analyzed to determine the virulence status of the bac-
terial strains. Pyrosequencing technology is a powerful
method to identify B. anthracis.
B
acillus anthracis is a gram-positive, rod-shaped,
spore-forming bacterium that causes the acute mam-
malian disease anthrax when endospores enter the body.
The infection is often fatal if not treated with antimicrobial
drugs before or when the first symptoms appear. The bac-
terium can infect livestock and humans by gastrointestinal,
cutaneous, or respiratory routes. Potentially, B. anthracis
spores can be an effective biological weapon because of
their high stability. They do not divide, have no metabo-
lism, and are resistant to drying, heat, UV light, and many
disinfectants. In 2001, letters containing anthrax spores
caused illness in 22 persons, leading to 5 deaths in the
United States.
B. anthracis has 2 plasmids: the toxin-encoding pXO1
(182 kb) and capsule-encoding pXO2 (95 kb) (1,2). Both
plasmids are required for virulence; lacking 1 of the plas-
mids attenuates the microorganism. The pXO1 plasmid
contains genes lef, cya, and pag, which encode the toxin’s
lethal factor, edema factor, and protective antigen, respec-
tively (3–5). The pXO2 plasmid contains the genes capA,
capB, and  capC, necessary for capsule formation (6).
These genes have been used as markers to identify B.
anthracis with polymerase chain reaction (PCR) in both
environmental and clinical samples (7–9).
Differentiating between B. anthracis and closely relat-
ed B. cereus and B. thuringiensis is difficult (10). Usually,
phenotypic characteristics, such as susceptibility to β-lac-
tam antimicrobial drugs, lack of hemolysis, lack of motili-
ty on sheep blood agar plate, and inability to ferment
salicin, are used to differentiate (11,12). A variety of chro-
mosomal markers that appear to be specific have been sug-
gested for genotypic species determination of B. anthracis
(13–18). We studied single nucleotide polymorphisms
(SNPs) in the rpoB gene, described by Qi et al. (13) by
using pyrosequencing technology (19). This technology
can determine SNPs and short DNA stretches in real time,
starting from PCR products. Biotinylated PCR amplicons
that cover the region of interest are immobilized onto solid
streptavidin coated beads and converted to single-stranded
form. A sequencing primer is hybridized to the single-
stranded DNA, and incorporation of added nucleotides is
detected as light peaks by an enzymatic cascade.
Enzymatic degradation of excess nucleotides allows the
reaction to be performed in a single tube. When one starts
from PCR products, <96 genetic targets can be sequenced
within 1 hour.
In this study, we used the rpoB gene as a chromosomal
marker to discriminate between B. anthracis and closely
related bacillus species. We studied 4 B. anthracis–specif-
ic rpoB SNPs located at positions 911, 912, 913, and 914
in duplex sequencing reactions by using a unique sequenc-
ing primer for each desired SNP in a collection of 17
anthracis and 10 non-anthracis Bacillus strains.
Simultaneously, we investigated the distribution of viru-
lence plasmids pXO1 and pXO2 among these strains by
using PCR and pyrosequencing technology to rapidly ver-
ify the amplicons.
Materials and Methods
Bacterial Strains and DNA Extraction
The B. anthracis reference strains used in this study
were obtained from the National Collection of Type
Cultures, London, England, and the Swedish Defense
Research Agency. Reference strains of B. cereus, B.
mycoides, and B. thuringiensis were obtained from the
Culture Collection University of Gothenburg of Sweden.
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tured on blood sheep agar at 37°C for 16 h, and genomic
DNA was prepared by using a commercially available
DNA extraction kit, QIAamp tissue protocol (Qiagen,
Hilden, Sweden). The DNAwas boiled at 99°C for 15 min,
plated on blood agar, and incubated for 3 days. No growth
was observed, and the DNA was removed from the
biosafety level 3 laboratory. All material, including the
DNA, is under the protection of our institute.
PCR
All reagents used for amplification of bacterial DNA
were from Amersham Biosciences (Uppsala, Sweden)
except for primers, which were from Invitrogen Life
Technologies (Paisley, United Kingdom). Table 2 shows
the primer sequences. The reverse primer for each PCR
fragment was biotinylated. PCR primers were designed to
amplify a 176-bp fragment of rpoB, 179 bp of the pXO1
plasmid, and 127 bp of the pXO2 plasmid. PCR was per-
formed in 50-µL reaction mixtures containing 1× PCR
buffer (10 mmol/L Tris-HCl, pH 8.3, 50 mmol/L KCl, 2.5
mmol/L MgCl2), 0.8 U Taq DNA polymerase, 0.2 mmol/L
each nucleotide, 0.1 µmol/L each primer and 5 µL eluate
containing DNA. The reaction mixture was subjected to
95°C for 5 min and 45 cycles of 95°C for 30 s, annealing
at 60°C for 30 s, and elongation at 72°C for 30 s, followed
by terminal extension at 72°C for 7 min.
Pyrosequencing Analysis
Two primers were designed to sequence of 30
nucleotides within the PCR amplicons generated from
plasmids pXO1 and pXO2, respectively. In addition, 1
sequencing primer was designed for each of the 4 rpoB
SNPs to be determined (Table 2). The rpoB primers were
used in duplex sequencing reactions so that primers 911
and 912 were combined in a single reaction for sequencing
of SNPs at positions 911 and 912, while primers 913 and
914 were used for combined sequencing of SNPs at posi-
tions 913 and 914. For sequencing according to the pyrose-
quencing technology, biotinylated PCR amplicons were
immobilized onto streptavidin-coated magnetic beads and
denatured to produce single-stranded DNAby using a PSQ
96 Sample Prep Tool (Biotage AB, Uppsala, Sweden).
Sequencing primers were added and allowed to hybridize
to the strands, after which sequencing was performed
according to the manufacturer’s instructions. All steps
were performed at room temperature.
Results
B. anthracis was unambiguously identified by deter-
mining 4 SNPs in the rpoB gene by using pyrosequencing
technology; thus, we were able to distinguish B. anthracis
from the other tested bacillus species. The Figure shows
representative output diagrams, or pyrograms, from duplex
sequencing reactions of the SNPs in B. anthracis National
Collection of Type Cultures 2026 and B. cereus Culture
Collection University of Gothenburg 7414. The specific
nucleotides 911C, 912T, 913C, and 914Awere found in all
B. anthracis strains tested and appear to be unique to B.
anthracis. The corresponding nucleotides in all tested non-
anthracis strains (B. cereus, B. thuringiensis, and B.
mycoides) were 911T, 912C, 913T, and 914G. In duplex
sequencing reactions, we could easily determine 2 SNPs in
each pyrogram (Figure). 
Presence of the virulence plasmids was determined by
PCR and sequence verification of regions on plasmids
pXO1 and pXO2 (Table 1). The assay was applied on 17
B. anthracis strains, 7 B. cereus strains, 2 B. thuringiensis
strains, and 1 B. mycoides strain. Of the 17 B. anthracis
isolates investigated, 9 isolates were positive for both
pXO1 and pXO2, while the remaining 8 lacked either 1 or
both of the virulence plasmids. All non-anthracis strains
were negative for both plasmids. pXO1 and pXO2 PCR
amplicons originating from the B. anthracis strains were
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quencing technology. The nucleotide sequence following
the sequencing primers located within the amplified frag-
ments was AAGATATTATCAAGGGATATTTTAAG-
TAAA for all pXO1 amplicons and ACCACTCATT-
AAGTTCTTCGCACCGCTAAA for all pXO2 amplicons,
which agreed with all nucleotide sequences of these
regions submitted to the GenBank nucleotide database
(http://www.ncbi.nlm.nih.gov), accession numbers
AF065404, AE011190, AJ413934, AE017336, AJ413935,
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Figure. Sequence analysis of single nucleotide polymorphisms (SNPs) in the rpoB gene of Bacillus anthracis National Collection of Type
Cultures (NCTC) 2026 (A and B) and B. cereus Culture Collection University of Gothenburg (CCUG) 7414 (C and D). The initial addition
of enzyme (E) and substrate (S) mixture and the sequential addition of nucleotides are shown on the x axis. An initial peak was gener-
ated when the substrate mixture was added due to pyrophosphate molecules remaining from the polymerase chain reaction (PCR).
Incorporation of added nucleotides was detected as light peaks, measured in relative light units as shown on the y-axis. Incorporation of
2 identical consecutive nucleotides gave rise to peaks that were higher than those generated when a single nucleotide was incorporat-
ed. The 4 SNPs were determined by using the 4 sequencing primers 911–914 in 2 duplex reactions per strain. The output sequence
reported by the software was a combination of the 2 unique sequences produced by each primer in the duplex reactions. The SNPs dis-
tinguishing B. anthracis NCTC 2026 from B. cereus CCUG 7414 are shown in bold.M29081, M30210, AF188935, AE011191, and AE017335.
B. anthracis was successfully identified by using pyrose-
quencing technology for genotyping 4 SNP positions of
the  rpoB gene, which appear to be specific for B.
anthracis, and 2 fragments of virulence plasmids pXO1
and pXO2.
Discussion
In biologic warfare, speed and accuracy are in high
demand for identifying and characterizing microbial
species. In this study, we investigated the possibility of
using pyrosequencing technology to rapidly identify and
characterize strains of B. anthracis and distinguish them
from related non-anthracis Bacillus strains. This method
has been used to analyze multiple targets that are important
in microbial infections (20,21).
By determining 4 SNPs in the rpoB gene, B. anthracis
strains were successfully identified. This chromosomal
marker can discriminate between B. anthracis and other
closely related species from the Bacillus genus. The 16S
rRNA gene cannot be relied upon to differentiate B.
anthracis from its close relatives; therefore, we did not
include this target in the assay (22). By careful design of
nucleotide dispensation order, multiple SNPs may be ana-
lyzed in 1 single sequencing reaction by using a unique
primer for each desired SNP. To save time and reduce
reagent cost, we analyzed the rpoB SNPs in duplex pyrose-
quencing reactions. The resulting pyrograms of overlap-
ping sequences were easily resolved by the accompanying
software (Figure). Using 1 well for all 4 SNP positions
may further optimize the method. 
This technology validates PCR-based assays by quali-
tatively verifying that a positive PCR result is not the
effect of nonspecific amplification, as shown here by
sequence verification of PCR amplicon generated from
virulence plasmids pXO1 and pXO2. The risk of false-pos-
itive results is thereby minimized.
We illustrate for the first time how pyrosequencing
technology can identify B. anthracis. Using this technolo-
gy in diagnostic laboratories is advantageous because it is
rapid, simple, nonradioactive, inexpensive, and automated.
It is a powerful method to rapidly determine genetic tar-
gets; as many as 96 samples can be analyzed in 40 minutes.
Genetic analysis with pyrosequencing technology could
make selecting antimicrobial drug treatment easier and
potentially complement typing methods and time-consum-
ing, traditional microbial identification, such as biochemi-
cal testing, phage lysing assays, and immunologic assays.
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